Really? Couldn't tell. Lol. Looking at SCMP, it may be a good short term stock for an April catalyst with the decision of the FDA looming. However, looking at strictly the results of the studies an such, it appears that Plecanatide is a far superior product in terms of negative side-effects and can treat a vast more amount of people. I am not invested in either company, but it appears that Plecanatide will be well received when it comes to the market.